학술논문
Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
Document Type
article
Author
Viktor Grünwald; Thomas Powles; Masatoshi Eto; Evgeny Kopyltsov; Sun Young Rha; Camillo Porta; Robert Motzer; Thomas E. Hutson; María José Méndez-Vidal; Sung-Hoo Hong; Eric Winquist; Jeffrey C. Goh; Pablo Maroto; Tomas Buchler; Toshio Takagi; Joseph E. Burgents; Rodolfo Perini; Cixin He; Chinyere E. Okpara; Jodi McKenzie; Toni K. Choueiri
Source
Frontiers in Oncology, Vol 13 (2024)
Subject
Language
English
ISSN
2234-943X